– Interview with Michael Tsang, Ph.D., Assistant Professor, Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine

Previous articleForest Licenses Antibiotic to AstraZeneca in Europe and Other Markets
Next articleAGI Regains North American Rights to Phase II GERD Therapy from Axcan Pharma